Press Releases from DelveInsight Business Research LLP (4751 total)
Acute Kidney Injury Clinical Trials | A Drug Pipeline Analysis Report 2024 | GUA …
DelveInsight's 'Acute Kidney Injury Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Acute Kidney Injury therapies in various stages of…
Degenerative Disc Disease Clinical Trials | A Drug Pipeline Analysis Report 2024 …
DelveInsight's 'Degenerative Disc Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Degenerative Disc Disease therapies in various stages of…
Dengue Clinical Trials | A Drug Pipeline Analysis Report 2024 | Takeda, Merck Sh …
United States, Nevada, Las Vegas, DelveInsight's 'Dengue Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Dengue therapies in various stages…
Diffuse Large B-Cell Lymphoma Clinical Trials | A Drug Pipeline Analysis Report …
United States, Nevada, Las Vegas, DelveInsight's 'Diffuse Large B-Cell Lymphoma Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diffuse Large…
Dermatomyositis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Corbus …
DelveInsight's 'Dermatomyositis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Dermatomyositis therapies in various stages of clinical development, major pharmaceutical…
Desmoid Tumors Clinical Trials | A Drug Pipeline Analysis Report 2024 | SpringWo …
United States, Nevada, Las Vegas, DelveInsight's 'Desmoid Tumors Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Desmoid Tumors therapies in…
Developmental and Epileptic Encephalopathy Clinical Trials | A Drug Pipeline Ana …
United States, Nevada, Las Vegas, DelveInsight's 'Developmental and Epileptic Encephalopathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Developmental and…
Diabetes Clinical Trials | A Drug Pipeline Analysis Report 2024 | Daewoong, Jans …
DelveInsight's 'Diabetes Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetes therapies in various stages of clinical development, major pharmaceutical…
Diabetic Foot Ulcer Clinical Trial Pipeline Analysis Featuring 34+ Key Companies …
DelveInsight's 'Diabetic Foot Ulcer Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Foot Ulcer therapies in various stages of…
Diabetic Kidney Disease Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
United States, Nevada, Las Vegas, DelveInsight's 'Diabetic Kidney Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Kidney Disease…
Diabetic Macular Edema Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
DelveInsight's 'Diabetic Macular Edema Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Macular Edema therapies in various stages of…
Diabetic Nephropathy Clinical Trials | A Drug Pipeline Analysis Report 2024 | Ba …
DelveInsight's 'Diabetic Nephropathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Nephropathy therapies in various stages of clinical development,…
Sickle Cell Disease Clinical Trials | A Drug Pipeline Analysis Report 2024 | Bel …
DelveInsight's 'Sickle Cell Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sickle Cell Disease therapies in various stages of…
Diabetic Neuropathic Pain Clinical Trials | A Drug Pipeline Analysis Report 2024 …
DelveInsight's 'Diabetic Neuropathic Pain Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Neuropathic Pain therapies in various stages of…
Diabetic Peripheral Neuropathy Clinical Trials, Key Companies, Emerging Therapie …
DelveInsight's 'Diabetic Peripheral Neuropathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Peripheral Neuropathy therapies in various stages of…
Short Bowel Syndrome Clinical Trials | A Drug Pipeline Analysis Report 2024 | Ze …
DelveInsight's 'Short Bowel Syndrome Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Short Bowel Syndrome therapies in various stages of…
Diffuse Cutaneous Systemic Sclerosis Clinical Trials | A Drug Pipeline Analysis …
DelveInsight's 'Diffuse Cutaneous Systemic Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diffuse Cutaneous Systemic Sclerosis therapies in various…
Severe Hypertriglyceridemia Clinical Trials | A Drug Pipeline Analysis Report 20 …
DelveInsight's 'Severe Hypertriglyceridemia Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Severe Hypertriglyceridemia therapies in various stages of clinical development,…
Septic Shock Clinical Trials | A Drug Pipeline Analysis Report 2024 | Adrenomed, …
DelveInsight's 'Septic Shock Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Septic Shock therapies in various stages of clinical development,…
Scars Clinical Trials | A Drug Pipeline Analysis Report 2024 | First String Rese …
United States, Nevada, Las Vegas, DelveInsight's 'Scars Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Scars therapies in various stages…
Schizophrenia Clinical Trials | A Drug Pipeline Analysis Report 2024 | Otsuka Ph …
DelveInsight's 'Schizophrenia Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Schizophrenia therapies in various stages of clinical development, major pharmaceutical…
Sciatica Clinical Trials | A Drug Pipeline Analysis Report 2024 | Sollis Therape …
United States, Nevada, Las Vegas, DelveInsight's 'Sciatica Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sciatica therapies in various stages…
Sepsis Clinical Trials | A Drug Pipeline Analysis Report 2024 | SciClone Pharmac …
DelveInsight's 'Sepsis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sepsis therapies in various stages of clinical development, major pharmaceutical…
Cystinosis FDA Approvals, Clinical Trials and Pipeline Insights 2024 | AVROBIO, …
DelveInsight's 'Cystinosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystinosis therapies in various stages of clinical development, major pharmaceutical…
Cytokine Release Syndrome FDA Approvals, Clinical Trials and Pipeline Insights 2 …
DelveInsight's 'Cytokine Release Syndrome Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cytokine Release Syndrome therapies in various stages of…
Cytomegalovirus FDA Approvals, Clinical Trials and Pipeline Insights 2024 | Mode …
DelveInsight's 'Cytomegalovirus Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cytomegalovirus therapies in various stages of clinical development, major pharmaceutical…
Cutaneous Lupus Erythematosus FDA Approvals, Clinical Trials and Pipeline Insigh …
United States, Nevada, Las Vegas, DelveInsight's 'Cutaneous Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cutaneous Lupus Erythematosus…
Deep Vein Thrombosis FDA Approvals, Clinical Trials and Pipeline Insights 2024 | …
United States, Nevada, Las Vegas, DelveInsight's 'Deep Vein Thrombosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Deep Vein Thrombosis…
Sepsis Drugs Market Size 2034 | La Jolla Pharmaceuticals, Par Pharmaceutical, On …
Sepsis Market Insights, Epidemiology, and Market Forecast-2034" offers a comprehensive understanding of Sepsis, including historical and projected epidemiology. Additionally, the report examines market trends for…
Aplastic Anemia Drugs Market Size 2034 | Pfizer, BioLineRx, Ltd., Regeneron Phar …
DelveInsight's "Aplastic Anemia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the aplastic anemia, historical and forecasted epidemiology as…
Nephrotic Syndrome Drugs Market Size 2034 | GlaxoSmithKline, Goldfinch Bio, Inc. …
DelveInsight's "Nephrotic Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Nephrotic Syndrome, historical and forecasted epidemiology, and…
Complement 3 Glomerulopathy Drugs Market Size 2034 | ChemoCentryx, Novartis Phar …
DelveInsight's "Complement 3 Glomerulopathy Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Complement 3 Glomerulopathy, historical and forecasted epidemiology…
Geographic Atrophy Drugs Market Size 2032 | Apellis Pharmaceuticals, Iveric Bio …
DelveInsight's "Geographic Atrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Geographic Atrophy, historical and forecasted epidemiology as well as…
Hidradenitis Suppurativa Drugs Market Size 2034 | Inflarx, Novartis Pharmaceutic …
DelveInsight's "Hidradenitis Suppurativa Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Hidradenitis Suppurativa, historical and forecasted epidemiology as well…
Glaucoma Drugs Market Size 2032 | Allergan, Sun Pharma Advanced Research Company …
DelveInsight's "Glaucoma Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Glaucoma, historical and forecasted epidemiology and the Glaucoma…
Retinitis Pigmentosa Drugs Market Size 2032 | Johnson & Johnson Innovative Medic …
DelveInsight's "Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of historical and forecasted epidemiology as well as the…
Peanut Allergy Drugs Market Size 2032 | Parexel, Regeneron Pharmaceuticals, Sano …
DelveInsight's "Peanut Allergy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Peanut Allergy, historical and forecasted epidemiology as well as…
Glioblastoma Multiforme Drugs Market Size 2032 | Genentech, Merck, Daiichi Sanky …
DelveInsight's 'Glioblastoma Multiforme Market Insights, Epidemiology and Market Forecast- 2032' report delivers an in-depth understanding of the Glioblastoma Multiforme, historical and forecasted epidemiology as well…
Cutaneous Lupus Erythematosus Clinical Trials, Emerging Therapies, Key Companies …
DelveInsight's 'Cutaneous Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cutaneous Lupus Erythematosus therapies in various stages of…
Dravet Syndrome Clinical Trials | A Drug Pipeline Analysis Report 2024 | Compani …
DelveInsight's 'Dravet Syndrome Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Dravet Syndrome therapies in various stages of clinical development;…
Diabetic Retinopathy Clinical Trials | A Drug Pipeline Analysis Report 2024 | Co …
DelveInsight's 'Diabetic Retinopathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Retinopathy therapies in various stages of clinical development,…
Cutaneous T-Cell Lymphoma Clinical Trials | A Drug Pipeline Analysis Report 2024 …
DelveInsight's 'Cutaneous T-Cell Lymphoma Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cutaneous T-Cell Lymphoma therapies in various stages of…
Cystic Fibrosis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Compani …
DelveInsight's 'Cystic Fibrosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystic Fibrosis therapies in various stages of clinical development,…
Heart Failure Drugs Market Size 2032 | Roche, Pfizer, Novo Nordisk, Merck & Co, …
DelveInsight's "Heart Failure Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Heart Failure, historical and forecasted epidemiology as well as…
Synovial Sarcoma Drugs Market Size 2032 | Takara Bio Inc., Foghorn Therapeutics …
DelveInsight's "Synovial Sarcoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Synovial Sarcoma, historical and forecasted epidemiology as well as…
Cutaneous T-Cell Lymphoma Drugs Market Size 2034 | BeiGene, Galderma R&D, Angimm …
DelveInsight's report titled "Cutaneous T-Cell Lymphoma Therapeutics Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of burns, historical and forecasted…
Parainfluenza Virus Infection Drugs Market Size 2032 | ModernaTX Inc., MedImmune …
DelveInsight's "Parainfluenza Virus Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Parainfluenza Virus Infection, historical and forecasted epidemiology as…
Chronic Kidney Disease FDA Approvals, Emerging Drugs, and Pipeline 2024 | Boehri …
DelveInsight's, "Chronic Kidney Disease Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape.…
Cirrhosis FDA Approvals, Clinical Trials and Pipeline Insights 2024 | GWOXI Stem …
DelveInsight's, "Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Cirrhosis pipeline landscape. It covers the Cirrhosis…
Alpha-1 Antitrypsin Deficiency FDA Approvals, Clinical Trials, and Pipeline 2024 …
DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers…
